trending Market Intelligence /marketintelligence/en/news-insights/trending/kIlfRRlfmxy2qXFOLT6Xrw2 content esgSubNav
In This List

German court dismisses Novartis appeal against Luye Pharma

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


German court dismisses Novartis appeal against Luye Pharma

The Court of Appeal for the district of Munich in Germany dismissed Novartis AG's appeal in a patent infringement lawsuit against Luye Pharma Group Ltd.'s Rivastigmine 1 day patch, a treatment for Alzheimer's disease.

Novartis also reimbursed the company of relevant legal expenses.